Literature DB >> 24105642

Cryptogenic stroke: how to define it? How to treat it?

Ava L Liberman1, Shyam Prabhakaran.   

Abstract

Stroke is a leading cause of disability worldwide. Cryptogenic strokes (CS) account for almost a quarter of ischemic strokes despite modern diagnostic evaluation. A working definition of CS based on stroke classification systems is essential for accurate conceptualization of this common entity. Mechanistic categories (potential paradoxical embolism; atherosclerotic disease of the aorta or supra-aortic vasculature; and occult arrhythmia) should aide in parsing the often heterogeneous mix of conditions included in the CS subtype. Despite efforts to unravel mechanisms of CS, specific or targeted recurrent stroke prevention strategies are lacking. For example, recent trials have shown no clear benefit of patent foramen ovale closure in stroke prevention after CS. There are promising ongoing clinical trials that will address appropriate diagnostic evaluations in CS as well as novel therapeutic interventions. Overall, a standardized approach must be framed to diagnose and manage patients with CS and guide clinical practice and future research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24105642     DOI: 10.1007/s11886-013-0423-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  104 in total

1.  Recurrent stroke on imaging and presumed paradoxical embolism: a cross-sectional analysis.

Authors:  Georgios D Kitsios; Aaron Lasker; Jasmeet Singh; David E Thaler
Journal:  Neurology       Date:  2012-03-14       Impact factor: 9.910

2.  Early transoesophageal echocardiography in cryptogenic and lacunar stroke and transient ischaemic attack.

Authors:  B Censori; F Colombo; M G Valsecchi; L Clivati; A Zonca; M Camerlingo; L Casto; M S De Tommasi; A Mamoli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

3.  Infarcts of undetermined cause: the NINCDS Stroke Data Bank.

Authors:  R L Sacco; J H Ellenberg; J P Mohr; T K Tatemichi; D B Hier; T R Price; P A Wolf
Journal:  Ann Neurol       Date:  1989-04       Impact factor: 10.422

4.  Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke.

Authors:  A Cohen; C Tzourio; B Bertrand; C Chauvel; M G Bousser; P Amarenco
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

Review 5.  Characterization of atherosclerotic plaques by magnetic resonance imaging.

Authors:  Z A Fayad; V Fuster
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

6.  Patent foramen ovale and prothrombotic markers in young stroke patients.

Authors:  Robert Belvís; Amparo Santamaría; Joan Martí-Fàbregas; Rubén G Leta; Dolores Cocho; Montserrat Borrell; Jordi Fontcuberta; Josep L Martí-Vilalta
Journal:  Blood Coagul Fibrinolysis       Date:  2007-09       Impact factor: 1.276

7.  Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.

Authors:  Steven R Levine; Robin L Brey; Barbara C Tilley; J L P Thompson; Ralph L Sacco; Robert R Sciacca; A Murphy; Yimeng Lu; Teresa M Costigan; Candi Rhine; Bruce Levin; Douglas A Triplett; J P Mohr
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

8.  Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.

Authors:  Vesa Karttunen; Leena Hiltunen; Vesa Rasi; Elina Vahtera; Matti Hillbom
Journal:  Blood Coagul Fibrinolysis       Date:  2003-04       Impact factor: 1.276

Review 9.  Classification of stroke subtypes.

Authors:  P Amarenco; J Bogousslavsky; L R Caplan; G A Donnan; M G Hennerici
Journal:  Cerebrovasc Dis       Date:  2009-04-03       Impact factor: 2.762

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  2 in total

1.  Propensity Score-Matched Analysis of Lesion Patterns in Stroke Patients With Patent Foramen Ovale and Patients With Spontaneous Intracranial Artery Dissection.

Authors:  Yangyang Huang; Yifan Cheng; Bei Shao; Xuanyou Zhou; Huazheng Liang; Jianhua Zhuang; Yong Bi
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

2.  Differentiating cerebral ischemia from functional neurological symptom disorder: a psychosomatic perspective.

Authors:  Carl E Scheidt; Kathrin Baumann; Michael Katzev; Matthias Reinhard; Sebastian Rauer; Michael Wirsching; Andreas Joos
Journal:  BMC Psychiatry       Date:  2014-05-29       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.